An Open-Label Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of a Single Dose of ANX005 in Participants With Guillain-Barré Syndrome. (FORWARD)

Principal Investigator

Dr Simon Rinaldi

Contact us

Email: dendron@ouh.nhs.uk

IRAS number

1012577